Figure 8.
![Figure 8. Minimal residual disease (MRD) kinetics after autologous stem cell transplantation (SCT) and non-myeloablative allogeneic SCT.40. / MRD levels (number of CLL specific DNA copies per total DNA copies in the sample compared to the reference [pre-therapeutic] sample) of patients after myeloablative conditioning and auto-SCT and after non myeloablative allogeneic SCT. Black-filled symbols (circles and triangles) denote MRD-positive samples whereas blank symbols denote the sensitivity of PCR-negative samples (calculated minimum MRD level, which would have been detected in this particular sample).](https://ash.silverchair-cdn.com/ash/content_public/journal/hematology/2004/1/10.1182_asheducation-2004.1.163/4/byrd_fig8.jpeg?Expires=1743019463&Signature=s-iLd9PyMPQYpJzXUoAh2XIzGALBqflFiaEyW0PwKquzeQ0brASw5i57E5qkeHNOYdtloIpWUYL8ZmBmGvzzM4h2dhWdQYRxaAjS1hkv29G6dGjtF1qMywNvyCqxlzpX7pNmZSG0sIXcZroOBY6XrNSOEjboo0C1NyTKaiP7NN~isQ0C3ptGI8JkYdvHqOomJYYrlMZfAK~O~iT4krxx0CZhlf7EqxXP~RkZ7PKOkf1PHRdGvWUskcCWpHbA6vZmP788ZElPKz7J2Gd0t-xTkCt1mcBj9iH8gE7GfShBnUobiQFp6fJTFwDDrXkNpLWScwtuS9FoEsecrCi5MZXuCQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Minimal residual disease (MRD) kinetics after autologous stem cell transplantation (SCT) and non-myeloablative allogeneic SCT.40
MRD levels (number of CLL specific DNA copies per total DNA copies in the sample compared to the reference [pre-therapeutic] sample) of patients after myeloablative conditioning and auto-SCT and after non myeloablative allogeneic SCT. Black-filled symbols (circles and triangles) denote MRD-positive samples whereas blank symbols denote the sensitivity of PCR-negative samples (calculated minimum MRD level, which would have been detected in this particular sample).
